Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,410
in 2 filings

Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lettmann Jason −$4K CHIEF EXECUTIVE OFFICER sold <1% of stake
  2. Wong Shelly −$1K SVP, FINANCE AND CAO sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-08-17 Lettmann Jason CHIEF EXECUTIVE OFFICER Sale −2,230 $1.93 $4K 294,379
2026-08-17 Wong Shelly SVP, FINANCE AND CAO Sale −573 $1.93 $1K 87,828
2026-07-01 Wong Shelly SVP, FINANCE AND CAO Sale −1,404 $2.04 $3K 88,401
2026-04-16 Knight Jeff E. Chief Dev & Operating Officer Grant or award · Stock option (right to buy) +800,000 800,000
2026-04-16 Klencke Barbara Chief Medical Officer Grant or award · Stock option (right to buy) +100,000 100,000
2026-03-19 Lettmann Jason CHIEF EXECUTIVE OFFICER Sale −12,311 $2.17 $27K 293,609
2026-03-19 Pinto Shelly SVP, FINANCE AND CAO Sale −903 $2.17 $2K 86,805
2026-03-03 Klencke Barbara Chief Medical Officer Grant or award · Stock option (right to buy) +700,000 700,000
2026-02-18 Pinto Shelly SVP, FINANCE AND CAO Sale −565 $2.27 $1K 87,708
2026-02-17 Lettmann Jason CHIEF EXECUTIVE OFFICER Shares withheld for taxes −2,201 $2.27 $5K 305,920
2026-02-02 GOODMAN COREY S Director Purchase +3,184,713 $1.57 $5.0M 8,453,038
2026-01-26 Shantharam Harish Chief Financial Officer Grant or award · Stock option (right to buy) +303,000 303,000
2026-01-26 Pinto Shelly SVP, FINANCE AND CAO Grant or award · Stock option (right to buy) +192,000 192,000
2026-01-26 Lettmann Jason CHIEF EXECUTIVE OFFICER Grant or award · Stock option (right to buy) +912,000 912,000
2026-01-20 GOODMAN COREY S Director Grant or award · Stock Option (right to buy) +40,400 40,400
2026-01-20 Garland J. Scott Director Grant or award · Stock option (right to buy) +40,400 40,400
2026-01-20 Sandler Alan B. Director Grant or award · Stock option (right to buy) +10,100 10,100
2026-01-20 Curran Daniel J. Director Grant or award · Stock Option (right to buy) +16,833 16,833
2026-01-20 Takimoto Chris H Director Grant or award · Stock option (right to buy) +40,400 40,400
2026-01-20 Hemrajani Rekha Director Grant or award · Stock option (right to buy) +40,400 40,400

Page 1 of 22 · 432 trades